Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,751
Total Claims
$953K
Drug Cost
937
Beneficiaries
$1,018
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-74%
Opioid rate vs peers
2.4% vs 9.2% avg
+41%
Cost per patient vs peers
$1,018 vs $719 avg
+78%
Brand preference vs peers
11.8% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.4%
Opioid Rate
236
Opioid Claims
$4,109
Opioid Cost
7.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,146 claims · $775K
Generic: 8,529 claims · $174K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 207 | $186K |
| Semaglutide | 79 | $108K |
| Apixaban | 95 | $77K |
| Dulaglutide | 40 | $67K |
| Insulin Aspart | 25 | $38K |
| Linagliptin | 42 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 55 | $31K |
| Sitagliptin Phosphate | 29 | $26K |
| Mirabegron | 30 | $14K |
| Ipratropium/Albuterol Sulfate | 14 | $9,528 |
| Insulin Degludec | 14 | $9,271 |
| Budesonide/Formoterol Fumarate | 15 | $9,056 |
| Fluticasone Propion/Salmeterol | 12 | $8,806 |
| Rosuvastatin Calcium | 231 | $7,564 |
| Levothyroxine Sodium | 438 | $6,167 |
Prescribing Profile
Patient Profile
73
Avg Age
64%
Female
1.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data